Weight gain single-handedly prevented by a gut microbe By Michael Franco December 18, 2025 This composite image shows the rod-shaped Turicibacter bacterium in the foreground, with a cross-section of ...

Among patients living with HIV receiving antiretroviral therapy (ART), 22% reported experiencing undesired weight gain in the past 12 months. Switching ART regimens and having a BMI indicative of ...

Weight gain during your period is temporary and usually ends once the period is over. Eating complex carbohydrates and reducing salt may help lessen weight gain during periods. Severe PMS symptoms may ...

This time of year can be tricky for those who are working toward a weight-loss goal or simply trying to maintain a healthy weight. Even those with the best of intentions can be thrown off by the ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination Dec 23 (Reuters) - ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

These famous faces have opened up about their differing weight loss journeys Stephanie Sengwe is a pop culture enthusiast with over 10 years of experience working as a digital writer, editor and ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...